Legal Representation
Attorney
Thomas W. Brooke
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 7, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 7, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 28, 2007 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 14, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 14, 2007 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 13, 2006 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 26, 2006 | I | PAPER RECEIVED | Loading... | |
| Apr 26, 2006 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 14, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 20, 2005 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 30, 2005 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Oct 27, 2005 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Oct 21, 2005 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 20, 2005 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Oct 20, 2005 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 7, 2005 | I | PAPER RECEIVED | Loading... | |
| Oct 7, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 14, 2005 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jun 13, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 13, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 19, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and veterinary preparations for the treatment of lipid and cholesterol disorders
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development in the pharmaceutical field for third parties; product research and development for third parties in the veterinary field
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
LIPID PHARMACEUTICALS
Classification
International Classes
005
042